Ainos vs Heartsciences
Ainos is the larger business, with $124,157 of revenue in fiscal 2025 against $4,319 for Heartsciences (28.7 times as much). Ainos grew faster (499.0% against -0.7%). Ainos kept more of each dollar of sales as profit: a net margin of -11897.0% against -211666.5%. Ainos carries less debt relative to equity (145.5% against 1602.3%).
| Latest fiscal year | AinosAIMD, 2025 | HeartsciencesHSCS, 2026 |
|---|---|---|
| Revenue | $124,157 | $4,319 |
| Revenue growth | 499.0% | -0.7% |
| Net income | −$14.8m | −$9.1m |
| Operating margin | -11268.3% | -194787.4% |
| Net margin | -11897.0% | -211666.5% |
| Return on equity | -128.0% | — |
| Free cash flow | −$4.6m | −$7.4m |
| Cash | $417,353 | $1.7m |
| Total debt | $11.0m | $3.6m |
| Debt to equity | 145.5% | 1602.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 41 | 14 |
| Market value | $4.6m | $11.6m |
| Price vs our value range | — | — |
| Moat score | 20 (Weak) | — |
| Insider trades, 12 months | 9 buys, 9 sales | 0 buys, 0 sales |